Ongoing work in our laboratory is aimed at characterising the relationship between peripheral-blood sCD163 levels and stroke-induced adaptive immune dysfunction, as CD163 may be therapeutically targetable as a means of rescuing adaptive immune responsiveness following stroke. Here, CD163 is linked to stroke disorder.